• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
Displaying 144-158 of 313 results

1023 Exhibit: Thiboutot 2007

Document IPR2019-00207, No. 1023-20 Exhibit - Thiboutot 2007 (P.T.A.B. Nov. 6, 2018)
[11-13] The most notable adverse effects of oral and bacterial components[2,3] but, until recently, the dapsone are haematological reactions, including inflammatory events were considered secondary oc- dose-dependent haemolysis and methaemoglobi- currences in the sequence of lesion development.
[5] These find- dehydrogenase (G6PD) deficiency are sensitive to ings support the classification of acne vulgaris as an these effects, since the absence of functional G6PD inflammatory skin disease as opposed to a keratino- can lead to haemolysis and denaturation of cyte/hyperproliferative disorder.
A subset of subjects then underwent a 14-day washout period and re- turned to the clinic for administration of a single dose of oral dapsone, given at the recommended 1 The use of trade names is for product identification purposes only and does not imply endorsement.
[9,13] In the studies reported here, We wish to acknowledge Christy Costello, ELS, and Denise haemoglobin levels remained stable throughout Galipeau, MSc, of QLT Inc., Vancouver, BC, Canada, who therapy with dapsone gel, and there were no ad- provided editorial assistance.
The oral comparison study was conducted in the General Clinical Research Center at the Pennsylvania State University College of Medicine, which was funded by National Institute of Health grants Mo1RR010732 and CO6RR016499.
cite Cite Document
Analyze

1013 Exhibit: US Patent Publ No 20070190019

Document IPR2019-00207, No. 1013-12 Exhibit - US Patent Publ No 20070190019 (P.T.A.B. Nov. 6, 2018)
Log in to see more
cite Cite Document
Analyze

2065 Exhibit: Exhibit 2065 Supplemental Declaration of David W Osborne, PhD served August 10, 2019

Document IPR2019-00207, No. 2065-137 Exhibit - Exhibit 2065 Supplemental Declaration of David W Osborne, PhD served August 10, 2019 (P.T.A.B. Dec. 20, 2019)
Log in to see more
cite Cite Document
Analyze

1043 Exhibit: Second Declaration for Dr Michniak Kohn

Document IPR2019-00207, No. 1043-135 Exhibit - Second Declaration for Dr Michniak Kohn (P.T.A.B. Nov. 1, 2019)
Log in to see more
cite Cite Document
Analyze

1073 Exhibit: Kircik 2018 CMS

Document IPR2019-00207, No. 1073-131 Exhibit - Kircik 2018 CMS (P.T.A.B. Nov. 1, 2019)
Log in to see more
cite Cite Document
Analyze

1071 Exhibit: Kircik 2017 CMS

Document IPR2019-00207, No. 1071-129 Exhibit - Kircik 2017 CMS (P.T.A.B. Nov. 1, 2019)
Log in to see more
cite Cite Document
Analyze

1068 Exhibit: Kircik DFD 2016

Document IPR2019-00207, No. 1068-126 Exhibit - Kircik DFD 2016 (P.T.A.B. Nov. 1, 2019)
Log in to see more
cite Cite Document
Analyze

2047 Exhibit: Exhibit 2047 Puavilai Article

Document IPR2019-00207, No. 2047-78 Exhibit - Exhibit 2047 Puavilai Article (P.T.A.B. Aug. 9, 2019)
Log in to see more
cite Cite Document
Analyze

2048 Exhibit: Exhibit 2048 WHO Alert No 117 LapDap

Document IPR2019-00207, No. 2048-79 Exhibit - Exhibit 2048 WHO Alert No 117 LapDap (P.T.A.B. Aug. 9, 2019)
Log in to see more
cite Cite Document
Analyze

2020 Exhibit: Exhibit 2020 Kircik 2010

Document IPR2019-00207, No. 2020-51 Exhibit - Exhibit 2020 Kircik 2010 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2063 Exhibit: Exhibit 2063 Michniak Kohn Deposition Transcript 2019 07 30

Document IPR2019-00207, No. 2063-94 Exhibit - Exhibit 2063 Michniak Kohn Deposition Transcript 2019 07 30 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2045 Exhibit: Exhibit 2045 FDA approval letter dated 772005

Document IPR2019-00207, No. 2045-76 Exhibit - Exhibit 2045 FDA approval letter dated 772005 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

2041 Exhibit: Exhibit 2041 Epiduo press release 2011

Document IPR2019-00207, No. 2041-72 Exhibit - Exhibit 2041 Epiduo press release 2011 (P.T.A.B. Aug. 9, 2019)

cite Cite Document
Analyze

3001 Exhibit: Ex 3001

Document IPR2019-00207, No. 3001-147 Exhibit - Ex 3001 (P.T.A.B. May. 22, 2020)

cite Cite Document
Analyze

2070 Exhibit: PTAB Conference Call Transcript 2020 01 17

Document IPR2019-00207, No. 2070-146 Exhibit - PTAB Conference Call Transcript 2020 01 17 (P.T.A.B. Jan. 30, 2020)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 10 11 12 13 14 ... >>